Skip to main content
Javed Butler, MD, Cardiology, Jackson, MS

Javed Butler MD

Heart Failure & Transplantation


President, Baylor Scott and White Research Institute Senior Vice President, Baylor Scott and White Health

Join to view full profile
  • 2500 N State StJackson, MS 39216

  • Phone+1 601-984-1000

  • Fax+1 601-984-6439

Dr. Butler is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Javed Butler, MD, MPH, MBA, is the President of the Baylor Scott and White Research Institute, and Senior Vice President and Maxwell A. and Gayle H. Clampitt Endowed Chair at the Baylor Scott and White Health in Dallas, TX. He is also the Distinguished Professor of Medicine at University of Mississippi in Jackson, MS. Prior to joining Baylor Scott and White Health, he served as the Patrick H. Lehan Chair in Cardiovascular Research, and Professor and Chairman of the Department of Medicine at the University of Mississippi, where he was also Professor of Physiology. Prior to joining the University of Mississippi, he was Charles A. Gargano Professor and Director of the Division of Cardiovascular Medicine and Co-Director of the Heart Institute at Stony Brook University, New York. He had served as the director for heart failure research at Emory University and director of the heart and heart-lung transplant programs at Vanderbilt University prior to that.
    He received his medical degree from the Aga Khan University and then completed residency training at Yale University, cardiology fellowship and advanced heart failure and transplant fellowships at Vanderbilt University, and cardiac imaging fellowship at the Massachusetts General Hospital at the Harvard Medical School. He has completed Master of Public Health degree from Harvard University and a Master in Business Administration from the Emory University.
    Dr. Butler is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 1995 - 1998
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1991 - 1994
  • Aga Khan Medical College
    Aga Khan Medical CollegeClass of 1990

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2006 - 2027
  • MS State Medical License
    MS State Medical License 2018 - 2027
  • NY State Medical License
    NY State Medical License 2014 - 2026
  • TN State Medical License
    TN State Medical License 1999 - 2007
  • CT State Medical License
    CT State Medical License 1994 - 1999
  • Advanced Heart Failure and Transplant Cardiology
    American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, IQHealth, HealthSentry and P2 Sentinel, Cerner Corporation, 2013, 2016-2017
  • CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2013, 2016-2017
  • CMS Meaningful Use Stage 2 Certification P2 Sentinel, Cerner Corporation, 2013, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults with Diabetes  
    Michael C Honigberg, Ravi B Patel, Javed Butler, Darren K Mcguire, JAMA Cardiology
  • Effect of a Self-Care Intervention on 90-Day Outcomes in Patients with Acute Heart Failure Discharged from the Emergency Department  
    Deborah J Diercks, Gregory J Fermann, Brian Hiestand, Joann Lindenfeld, Jennifer Martindale, Javed Butler, JAMA Cardiology
  • Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical Practice  
    Muthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology

Lectures

  • Heart Failure Prevention for All 
    Heart Failure Society of America, Bloomington, Minnesota - 9/27/2012
  • Guideline Directed Management of a NYHA Class III Patient: How to Titrate What to Avoid Tools for Success and Practical Pearls 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Selecting A First-Choice Therapy For Systolic HF: The Growing Body of Evidence 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

  • Trends in HF Hospitalizations Among Young Adults in the United States from 2004 to 2018May 2022
  • Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureAugust 2020
  • Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureAugust 2020

Press Mentions

  • Baylor Scott & White Research Institute to Lead National Study on Advanced Chronic Kidney Disease Treatment
    Baylor Scott & White Research Institute to Lead National Study on Advanced Chronic Kidney Disease TreatmentApril 28th, 2026
  • Online Exclusive | the Changing Face of Heart Failure in America
    Online Exclusive | the Changing Face of Heart Failure in AmericaJanuary 21st, 2026
  • FDA Approves at-Home Version of Lasix for Heart Failure Care
    FDA Approves at-Home Version of Lasix for Heart Failure CareOctober 11th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: